Skip to search.
 TSX Up 0.44% TSX Ventures Up 0.66%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
3.14 Down 0.07(2.18%) 1:04PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:3.21
Open:3.17
Bid:3.15 x 300
Ask:3.16 x 1100
1y Target Est:6.50
Beta:2.55
Earnings Date:Aug 3 - Aug 7 (Est.)
Day's Range:3.12 - 3.33
52wk Range:1.56 - 5.20
Volume:558,978
Avg Vol (3m):889,341
Market Cap:276.77M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLDown 2.18%276.77M
AMGNUp 0.03%116.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.85
Quarterly EPS Est (Jun-15) :-0.22
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disord... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback